Related Experiment Video
Updated: Mar 19, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Genomic and functional characterization of a lytic Klebsiella phage UHKP with antibiofilm activity
Muhammad Hassan1, Iqbal Ahmad Alvi2,3, Sadiq Noor Khan1
1Department of Medical Lab Technology, The University of Haripur, Haripur, Khyber Pakhtunkhwa, Pakistan.
Abstract:
Klebsiella pneumoniae is an opportunistic pathogen causing severe hospital-acquired infections, and it rapidly acquires multidrug resistance. Its robust biofilm formation further complicates treatment and drives interest in phage therapy. A phage UHKP was isolated from hospital sewage using an MDR K. pneumoniae strain (KP-03). UHKP formed clear plaques and having phage titer 2.3 × 109 PFU/mL. Host-range testing on 19 clinical isolates showed a narrow spectrum. Only four MDR strains (KP-03, KP-05, KP-08, KP-11) and one K-17 serotype were lysed, with no activity on other strains or species. One-step growth analysis yielded a 30 min latent period and 85 PFU burst size. In planktonic culture, UHKP at MOI 1 stopped bacterial growth by 4 h and cleared cultures by 8 h, whereas at MOI 0.1 killing was delayed and incomplete. In static biofilm assays, UHKP eradicated 98% of 24-h and 96% of 48-h biofilm biomass by 24 h (MOI 1). Clearance of 72 - 96 h biofilms was limited (≤ 87% by 24 h). UHKP possesses an icosahedral head of 56 ± 3 nm and a short, non-contractile tail measuring around 15 ± 2 nm. Genome sequencing revealed a 62,542 bp dsDNA genome (56.6% GC) encoding 77 ORFs, and phylogenetic analysis placed UHKP in the genus Lastavirus. UHKP carries no lysogeny, toxin or antibiotic-resistance genes.
Insights
A novel bacteriophage, UHKP, effectively combats multidrug-resistant Klebsiella pneumoniae biofilms. This phage shows promise for treating hospital-acquired infections caused by this opportunistic pathogen.
Area of Science:
- Microbiology
- Virology
- Infectious Diseases
Background:
- Klebsiella pneumoniae is a major cause of hospital-acquired infections.
- Multidrug resistance and biofilm formation in K. pneumoniae complicate treatment.
- Bacteriophage therapy is a potential alternative to antibiotics.
Purpose of the Study:
- To isolate and characterize a bacteriophage effective against multidrug-resistant K. pneumoniae.
- To evaluate the efficacy of the isolated phage against planktonic and biofilm forms of K. pneumoniae.
- To determine the genomic and morphological properties of the novel phage.
Main Methods:
- Isolation of bacteriophage UHKP from hospital sewage using a multidrug-resistant K. pneumoniae strain.
- Host-range determination, plaque assays, and one-step growth analysis.
- Transmission electron microscopy and whole-genome sequencing.
- Assessment of lytic activity against planktonic and biofilm cultures.
Main Results:
- Phage UHKP demonstrated lytic activity against four multidrug-resistant K. pneumoniae clinical isolates and one K-17 serotype.
- UHKP exhibited a latent period of 30 minutes and a burst size of 85 PFU.
- The phage eradicated significant amounts of 24-h and 48-h K. pneumoniae biofilms (98% and 96% respectively) at MOI 1.
- Genome analysis revealed a 62,542 bp dsDNA genome encoding 77 ORFs, placing UHKP in the Lastavirus genus, with no identified lysogeny, toxin, or antibiotic-resistance genes.
Conclusions:
- Phage UHKP is a potent lytic bacteriophage with specific activity against certain multidrug-resistant K. pneumoniae strains.
- UHKP demonstrates significant efficacy in eradicating established K. pneumoniae biofilms.
- The characterized phage UHKP represents a promising candidate for phage therapy against K. pneumoniae infections.
Related Concept Videos
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
Viral Replication: Lytic Cycle
Viral Replication: Lysogenic Cycle
DNA Bacteriophages
Gene Regulation in Microbial Communities: Quorum Sensing

